The following is a summary of “Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS),” published by Sacca, et al.
Our research aimed to create a trustworthy tablet version of the Brief International Cognitive Assessment for Multiple Sclerosis (iBICAMS). The BICAMS is the gold standard for diagnosing MS-related cognitive impairment. Paper versions exist, but their administration and scoring processes are laborious and prone to mistakes. In two separate sessions, we gave the BICAMS and iBICAMS to 139 MS patients. Using a paired t-test, we compared the mean scores from each version. We utilized a repeated-measures variance analysis to examine how rater, administration order, and duration between tests affected test-retest scores. To measure the consistency of BICAMS and iBICAMS, we employed the Intraclass Correlation Coefficient (ICC).
There were distinctions between the paper and tablet forms of the BICAMS’s three exams (SDMT, CVLT-II, and BVMT-R). Test-retest results on the SDMT (P<0.001), CVLT- II (P<0.001), and BVMT-R (P<0.001) were affected by order of administration. The Intraclass coefficient correlation (ICC) for the SDMT (0.92), CVLT-II (0.83), and BVMT-R (0.82) all showed that the paper BICAMS and the iPad version were highly congruent with one another. According to the findings, adopting the iBICAMS increases the likelihood that tests will be administered and scored consistently. The intrinsic benefits of automated scoring and the remarkable consistency across the two versions point to the iBICAMS as the superior approach.
Source: index.mirasmart.com/aan2023/PDFfiles/AAN2023-003686.html
